Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cytosorbents Corp Director's Dealing 2011

Mar 11, 2011

34501_dirs_2011-03-11_04af324d-1e98-4f44-b1d7-7f95575ac1bd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2011-01-21

Reporting Person: Kraus Al (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-01-21 Stock Option $0.138 A 200000 Acquired 2021-01-21 Common Stock (200000) Direct

Footnotes

F1: As compensation for services rendered, on January 21, 2011, Mr. Al Kraus was issued an option to purchase 200,000 shares of
common stock at an exercise price of $0.138 per share which will expire on January 21, 2021.